# Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea

> **NCT05719896** · PHASE2 · UNKNOWN · sponsor: **Centre of Clinical Pharmacology, Hanoi Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** DT01 tablets
- **DRUG:** Placebo tablets
- **DRUG:** DT01-Placebo tablets

## Key facts

- **NCT ID:** NCT05719896
- **Lead sponsor:** Centre of Clinical Pharmacology, Hanoi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05719896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05719896, "Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05719896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*